Evidence brief · printable

Myelodysplastic Syndrome evidence brief

One page, every section sourced. Print it or bring it on your phone.

  1. Research Tracker
  2. Evidence briefs
  3. Myelodysplastic Syndrome

Print or save as PDF Fits on one A4 or Letter page.

Myelodysplastic Syndrome: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/myelodysplastic-syndrome.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Cyclosporine 10 trials
  • Cyclophosphamide 8 trials
  • Busulfan 7 trials
  • Azacitidine 6 trials
  • Cytarabine 6 trials
  • Fludarabine phosphate 6 trials

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Education, coaching and self-management 9 trials · 6 completed · 2 with results
  • Vitamin D 5 trials · 3 completed · 1 with results
  • Mindfulness, meditation and relaxation 2 trials · 1 completed · 1 with results
  • Hyperbaric oxygen therapy 1 trials · 1 completed · 1 with results
  • Psychotherapy, counselling and peer support 4 trials · 2 completed · 0 with results
  • Vitamin C 4 trials · 2 completed · 0 with results

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic… NCT07319845
  • Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and… NCT06303193
  • A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or… NCT06499285
  • Pre-myeloid Cancer and Bone Marrow Failure Clinic Study NCT02958462
  • Compassionate Communication and Advance Care Planning to Improve End of Life Care… NCT05444348
  • HEME Home Transfusion Program NCT06487247

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Among 9 trials of cognitive training and education found, none measured inflammation and other biomarkers 8 trials of other approaches did
  • Among 22 trials of supplements and nutraceuticals found, none measured mood, anxiety and wellbeing 6 trials of other approaches did
  • Among 9 trials of cognitive training and education found, none measured symptom severity and disease activity 6 trials of other approaches did
  • Exercise and physical activity: physical function and exercise capacity 4 trials, no results posted yet
  • Supplements and nutraceuticals: feasibility, adherence and safety 4 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (53 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.